Licciardone John C, Pandya Vishruti
Department of Family Medicine, University of North Texas Health Science Center, Fort Worth, TX 76203, USA.
Healthcare (Basel). 2020 Oct 1;8(4):381. doi: 10.3390/healthcare8040381.
This study was conducted to determine the feasibility of providing an eHealth intervention for health-related quality of life (HRQOL) to facilitate patient self-management.
A randomized controlled trial was conducted from 2019-2020 within the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation. Eligible patients included those with chronic low back pain and a SPADE (sleep disturbance, pain interference with activities, anxiety, depression, and low energy/fatigue) cluster score ≥ 55 based on the relevant scales from the Patient-Reported Outcomes Measurement Information System instrument with 29 items (PROMIS-29). Patients were randomized to the eHealth treatment group, which received a tailored HRQOL report and interpretation guide, or to a wait-list control group. The primary outcome was change in the SPADE cluster score, including its five component scales, over 3 months. Secondary outcomes were changes in low back pain intensity and back-related disability. Treatment effects were measured using the standardized mean difference (SMD) in change scores between groups. The eHealth intervention was also assessed by a survey of the experimental treatment group 1 month following randomization.
A total of 102 patients were randomized, including 52 in the eHealth treatment group and 50 in the wait-list control group, and 100 (98%) completed the trial. A majority of patients agreed that the HRQOL report was easy to understand (86%), provided new information (79%), and took actions to read or learn more about self-management approaches to improve their HRQOL (77%). Although the eHealth intervention met the criteria for a small treatment effect in improving the overall SPADE cluster score (SMD = 0.24; = 0.23) and anxiety (SMD = 0.24; = 0.23), and for a small-to-medium treatment effect in improving depression (SMD = 0.37; = 0.06) and back-related disability (SMD = 0.36; = 0.07), none of these results achieved statistical significance because of limited sample size.
Given the feasibility of rapid online deployment, low cost, and low risk of adverse events, this eHealth intervention for HRQOL may be useful for patients with chronic pain during the COVID-19 pandemic.
本研究旨在确定提供一项针对健康相关生活质量(HRQOL)的电子健康干预措施以促进患者自我管理的可行性。
2019年至2020年在疼痛流行病学、临床、介入研究与创新登记处开展了一项随机对照试验。符合条件的患者包括患有慢性下腰痛且根据患者报告结局测量信息系统工具(PROMIS - 29)的相关量表得出的SPADE(睡眠障碍、疼痛对活动的干扰、焦虑、抑郁以及精力不足/疲劳)聚类评分≥55的患者。患者被随机分为电子健康治疗组,该组接受一份量身定制的HRQOL报告及解读指南,或分为等待名单对照组。主要结局是3个月内SPADE聚类评分及其五个分量表的变化。次要结局是下腰痛强度和背部相关残疾的变化。使用两组变化分数的标准化均数差(SMD)来衡量治疗效果。在随机分组1个月后,还通过对实验治疗组的一项调查来评估电子健康干预措施。
总共102名患者被随机分组,其中电子健康治疗组52名,等待名单对照组50名,100名(98%)完成了试验。大多数患者认为HRQOL报告易于理解(86%)、提供了新信息(79%),并且采取行动阅读或了解更多关于自我管理方法以改善其HRQOL(77%)。尽管电子健康干预在改善总体SPADE聚类评分(SMD = 0.24;P = 0.23)和焦虑(SMD = 0.24;P = 0.23)方面达到了小治疗效果的标准,在改善抑郁(SMD = 0.37;P = 0.06)和背部相关残疾(SMD = 0.36;P = 0.07)方面达到了中小治疗效果的标准,但由于样本量有限,这些结果均未达到统计学显著性。
鉴于快速在线部署的可行性、低成本以及不良事件风险低,这种针对HRQOL的电子健康干预措施在新冠疫情期间可能对慢性疼痛患者有用。